AptaBio Therapeutics Inc. (KOSDAQ:293780)
South Korea flag South Korea · Delayed Price · Currency is KRW
8,400.00
+180.00 (2.19%)
Oct 10, 2025, 3:30 PM KST

AptaBio Therapeutics Revenue

AptaBio Therapeutics had revenue of 1.12B KRW in the quarter ending June 30, 2025, with 0.18% growth. This brings the company's revenue in the last twelve months to 3.11B, up 51.25% year-over-year. In the year 2024, AptaBio Therapeutics had annual revenue of 3.36B with 937.76% growth.

Revenue (ttm)
3.11B
Revenue Growth
+51.25%
P/S Ratio
75.45
Revenue / Employee
n/a
Employees
n/a
Market Cap
234.52B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20243.36B3.04B937.76%
Dec 31, 2023323.87M275.52M569.80%
Dec 31, 202248.35M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition